Found: 15
Select item for more details and to access through your institution.
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 542, doi. 10.3390/jpm11060542
- By:
- Publication type:
- Article
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 8, p. 1791, doi. 10.1038/s44321-024-00098-y
- By:
- Publication type:
- Article
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2676, doi. 10.3390/ijms24032676
- By:
- Publication type:
- Article
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13241, doi. 10.3390/ijms232113241
- By:
- Publication type:
- Article
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9880, doi. 10.3390/ijms23179880
- By:
- Publication type:
- Article
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9797, doi. 10.3390/ijms23179797
- By:
- Publication type:
- Article
Understanding LAG-3 Signaling.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 10, p. 5282, doi. 10.3390/ijms22105282
- By:
- Publication type:
- Article
Hyperprogressive Disease: Main Features and Key Controversies.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3736, doi. 10.3390/ijms22073736
- By:
- Publication type:
- Article
CAR-T Cells for the Treatment of Lung Cancer.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/life12040561
- By:
- Publication type:
- Article
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer.
- Published in:
- EMBO Reports, 2023, v. 24, n. 8, p. 1, doi. 10.15252/embr.202255884
- By:
- Publication type:
- Article
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184464
- By:
- Publication type:
- Article
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3846, doi. 10.3390/cancers14163846
- By:
- Publication type:
- Article
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 5, p. 869, doi. 10.1038/s41416-023-02561-y
- By:
- Publication type:
- Article
Cutting-Edge CAR Engineering: Beyond T Cells.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3035, doi. 10.3390/biomedicines10123035
- By:
- Publication type:
- Article
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 15, p. 2351, doi. 10.3390/cells11152351
- By:
- Publication type:
- Article